CVS HEALTH Corp
Company Stats
- Market Cap
- $109.6B
- as of Sep 30, 2026
- Enterprise Value
- $164.9B
- Shares Outstanding
- 1.3B
- Free Float
- 99.5%
Income Statement
- Revenue
- $402.1B
- Operating Income
- $4.7B
- Net Income
- $1.8B
- EBITDA
- $9.3B
- Non-cash Impairment
- $5.7B
- Revenue Growth, 3Y
- 7.6%
- FCF Margin, 3Y Avg
- 2.2%
- FCF Margin, Worst Year
- 1.7%
Cash Flow
- Free Cash Flow
- $7.8B
- FCF Yield
- 7.1%
- Owner FCF Yield
- 6.6%
Balance Sheet
- Cash & Equivalents
- $8.5B
- Total Debt
- $63.7B
- Net Debt
- $55.3B
- Net Debt / EBITDA
- 5.96x
- EV / EBITDA
- 17.79x
- Net Debt / EBIT
- 11.86x
Returns & Capital
- Dividends Paid
- $3.4B
- Dividend Yield
- 3.1%
- Dividend Payout, 3Y Avg
- 100.9%
- Buyback Yield, 3Y Avg
- 1.5%
- SBC, 3Y Avg
- $554.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $402.1B | $7.8B | 1.9% |
| FY2024 | $372.8B | $6.3B | 1.7% |
| FY2023 | $357.8B | $10.4B | 2.9% |
| FY2022 | $322.5B | $13.4B | 4.2% |
| FY2021 | $292.1B | $15.7B | 5.4% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 7, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges